Printer Friendly

Browse Multiple myeloma topic

Care and treatment subtopic

 

Articles

1-142 out of 142 article(s)
Title Author Type Date Words
United States : Amgen Announces Top-line Results from Phase 3 FOCUS Trail of KYPROLIS in Patients with Relapsed and Advanced Refractory Multiple Myeloma. Financial report Aug 14, 2014 241
Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis In Patients With Relapsed And Advanced Refractory Multiple Myeloma. Aug 13, 2014 2559
United Kingdom : Amgen Announces Phase 3 ASPIRE Trial of Kyprolis in Patients with Relapsed Multiple Myeloma Met Primary Endpoint. Aug 5, 2014 111
Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis In Patients With Relapsed Multiple Myeloma Met Primary Endpoint. Aug 4, 2014 2864
Belgium : Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA for use in the Treatment of Two Forms of Blood Cancer. Jul 26, 2014 425
Therapeutic Class Overview: Treating Refractory Hematological Malignancies. Disease/Disorder overview Mar 27, 2014 410
Therapeutic Class Overview: Treating Refractory Hematological Malignancies. Disease/Disorder overview Mar 27, 2014 438
Concise Analysis on Treating Refractory Hematological Malignancies for Multiple Myeloma. Mar 26, 2014 532
Concise Analysis on Treating Refractory Hematological Malignancies for Multiple Myeloma. Mar 26, 2014 554
Switzerland : Novartis announces positive Phase III study for JakaviA in patients with rare blood cancer polycythemia vera. Mar 8, 2014 400
Whole body MRI can improve cancer treatment: study. Feb 26, 2014 278
Dosing chemotherapy agents in hemodialysis--A focus on multiple myeloma. Runnels, Rachel; Cameron, Karen; Ng, Pamela; Battistella, Marisa Report Jan 1, 2014 3896
Missed opportunity in cancer feature. Dec 13, 2013 202
I've putt my cancer hell behind me; Brave dad credits new treatments for helping him fight deadly disease. Nov 15, 2013 449
Quality of life and supportive care in multiple myeloma / Multiple Myelomada Yasam Kalitesi ve Destek Tedavisi. Comert, Melda; Gunes, Ajda Ersoy; Sahin, Fahri; Saydam, Guray Report Sep 1, 2013 7722
Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents? / Yeni ilaclarin Doneminde, Multiple Myelomada Kok Hucre Nakli icin Uygun Bir Zamanlama Var midir? Toprak, Selami Kocak Clinical report Sep 1, 2013 1285
Akromegali ve Multiple Myeloma Birlikteligi: Bir Olgu Sunumu: association of Acromegaly and Multiple Myeloma: A Case Report. Atmaca, Murat; Yildiz, Saliha; Kalan, Isilay; Ozbay, Mehmet Fatih; Seven, Ismet; Ozturk, Mustafa Case study Sep 1, 2013 1995
Genes study gives hope in fight against myeloma. Aug 19, 2013 342
Belgium : European Commission Approves VELCADE As A Frontline Induction Therapy Before Stem Cell Transplantation. Aug 10, 2013 233
Belgium,United States : CHMP Gives A Positive Opinion For The Use Of VELCADEA As Retreatment And For Frontline Induction Therapy Before Stem Cell Transplantation. Jun 29, 2013 414
Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy. Jun 3, 2013 1121
Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy. Jun 3, 2013 1126
Carbamazepine and multiple myeloma possible interaction / Karbamazepin ve Multipl Miyelom: Olasi iliski. Gunaldi, Meral; Paydas, Semra; Afsar, cigdem Usul; Duman, Berna Bozkurt; Ercolak, Vehbi; Haksoyler, Letter to the editor Mar 1, 2013 866
The Cure Panel Talk Show Featuring Physicians in Conversation with Patients About New Treatments Creates National Interest. Dec 16, 2012 790
Ligand Initiates Pivotal Trial of Captisol-Enabled[R], Propylene Glycol-Free Melphalan in Patients with Multiple Myeloma. Dec 10, 2012 1058
Canada : Onyx Pharmaceuticals Completes Enrollment in FOCUS Phase 3 Carfilzomib Trial in Patients with Relapsed and Refractory Multiple Myeloma. Oct 16, 2012 229
NextBio Teams With Emory University for Cancer Biomarker Discovery. Sep 24, 2012 649
Non-secretory multiple myeloma in a hemodialysis patient with Hypercalcemia / Hiperkalsemi Saptanan Hemodiyaliz Hastasinda Nonsekretuar Multipl Miyelom Tanist. Erdur, Fatih Mehmet; Soyorall, Yasemin Usul; Emre, Habib; Begenikt, Huseyin; Tasdemir, Mehmet; Erkoc Case study Sep 1, 2012 786
First-Line Multiple Myeloma Patient Share in Europe is Variable by Country and Dependent on Patient Eligibility for Stem-Cell Transplantation; Overall, Janssen's Velcade Dominates. Aug 28, 2012 686
Senesco Announces that SNS01-T Showed Good Tolerability and Stable Disease in Newly Completed First Cohort of Phase 1b/2a Multiple Myeloma Trial. Aug 15, 2012 1094
Onyx Pharmaceuticals Announces Kyprolis(TM) Study Published in the Medical Journal Blood. Jul 25, 2012 1487
Canada : Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis (carfilzomib) for Injection. Jul 21, 2012 406
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection. Jul 20, 2012 1786
Kyprolis[TM] (carfilzomib) for Injection Receives Accelerated Approval from FDA for Advanced Multiple Myeloma. Jul 20, 2012 986
Ligand Licensee Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis[TM] (carfilzomib) for Injection. Jul 20, 2012 1406
Onyx Pharmaceuticals Initiates Phase 3 Kyprolis(TM) Head-to-Head Comparison Trial vs. Velcade in Patients with Relapsed Multiple Myeloma. Jul 2, 2012 1099
Primary solitary extramedullary plasmacytoma of the tongue. Onal, Cem; Oymak, Ezgi; Uguz, Aysun; Ergin, Melek Case study Jul 1, 2012 2295
Millennium Initiates TOURMALINE-MM1 Pivotal Phase 3 Trial of MLN9708 in Patients With Relapsed and/or Refractory Multiple Myeloma. Jun 28, 2012 468
Onyx Pharmaceuticals and the University of Texas MD Anderson Cancer Center Announce Strategic Alliance in Multiple Myeloma and Lymphoma. Jun 4, 2012 949
Drug combination highly effective for newly diagnosed myeloma patients. Jun 4, 2012 574
Myeloma cells with Auer rod-like inclusions / Auer Cubugu Benzeri Inkluzyonlara Sahip Myeloma Hucreleri. Abdulsalam, Abbas Hashim; Al-yassin Fatin, Mohammed Brief article Jun 1, 2012 267
Pre-Clinical Data Demonstrates Promising Potential of MannKind's IRE1 Inhibitor to Treat Multiple Myeloma. May 31, 2012 720
Over 90 Percent of Surveyed Hematologist-Oncologists in the U.S. are Aware that Takeda/Millennium's Subcutaneous Velcade is Approved for the Treatment of Myeloma. May 22, 2012 750
Distended epidural varix. Schettino, Chris; Horner, Neil; Knightly, Jack Case study Jan 1, 2012 1122
Southampton Varsity research reveals new ways to treat blood cancers. Dec 22, 2011 456
Mayo Clinic Study May Help Physicians Determine How Patients Will Respond to Multiple Myeloma Therapy. Dec 20, 2011 477
The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study. Dec 19, 2011 1010
Mayo Clinic Study May Help Physicians Determine How Patients Will Respond to Multiple Myeloma Therapy. Dec 15, 2011 468
Landmark VISTA Trial Shows Significant Long-Term Overall Survival Benefit of VELCADE (Bortezomib) in Patients With Previously Untreated Multiple Myeloma. Dec 12, 2011 1620
Multiple Myeloma Research Consortium (MMRC) Welcomes the Barbara Ann Karmanos Cancer Institute as Member Institution. Dec 2, 2011 769
AB Science Announces Recruitment of First Patient in Phase 3 Study of Masitinib in Multiple Myeloma. Clinical report Oct 17, 2011 1016
Multiple myeloma presenting as acute renal failure. Kuo, Vincent C.; Fenves, Andrew Z.; Mehta, Ankit N. Clinical report Oct 1, 2011 3323
Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites. Sep 20, 2011 1178
Researchers Find RapidArc Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers. Aug 8, 2011 1210
KP govt to provide free treatment for blood cancer patients. Aug 8, 2011 110
Millennium Submits Supplemental New Drug Application with FDA for Long-Term Overall Survival Results of VELCADE in Previously Untreated Multiple Myeloma. Jul 19, 2011 1637
Eighth Annual Multiple Myeloma Research Foundation (MMRF) Race for Research: Tri-State 5K Walk/Run Raises Over $335,000 for Cancer Research. Jun 14, 2011 905
Ninth Annual Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York Raises Over $620,000 for Blood Cancer Research. May 17, 2011 1026
The International Myeloma Foundation Says Major Medical Meeting in Paris Will Support New Treatment Options for Patients. May 3, 2011 784
The Journal of Clinical Oncology Publishes Phase 3 XGEVA(TM) (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma. Clinical report Feb 22, 2011 2449
The Highest Proportion of Surveyed Oncologists and MCOs Indicate That Bortezomib/Lenalidomide/Dexamethasone is the Most Efficacious Treatment for Relapsed/Refractory Multiple Myeloma, When Compared to Other Currently Available Therapies. Jan 31, 2011 694
Multiple Myeloma Research Foundation (MMRF) Invests $3 Million in Development of Next-Generation Treatments. Jan 6, 2011 1026
VELCADE Induction Followed by VELCADE Maintenance Improves Clinical Outcomes in Previously Untreated Multiple Myeloma Patients. Clinical report Dec 9, 2010 2446
REVLIMID[R] Data in Patients with Multiple Myeloma Evaluating Surival Rates with Low- and High-Dose Dexamethasone with Respect to Age. Clinical report Dec 6, 2010 2461
Webcast Alert: Continuous Therapy in Multiple Myeloma - Science Media Workshop. Dec 6, 2010 501
Updated Clinical Results from REVLIMID[R] Continuous Treatment Phase III Study Show Statistically Significant Improvement in Progression-Free Survival in Patients Newly Diagnosed with Multiple Myeloma. Clinical report Dec 6, 2010 2748
Array BioPharma's Arry-520 Demonstrates Single Agent Activity in Advanced Multiple Myeloma Patients. Dec 4, 2010 1274
Phase III Study Evaluating REVLIMID[R] in Patients with High-Risk Smoldering Multiple Myeloma Reported Statistically Significant Reduction in Risk of Disease Progression. Dec 4, 2010 2617
Webcast Alert: Continuous Therapy in Multiple Myeloma - Science Media Workshop. Dec 1, 2010 469
Bisphosphonate-associated osteonecrosis of the jaw. Ferrara, Mark G. Case study Dec 1, 2010 2078
Webcast Alert: Continuous Therapy in Multiple Myeloma - Science Media Workshop. Nov 30, 2010 501
Improving multiple myeloma diagnosis. Brief article Nov 1, 2010 188
Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma. Clinical report Aug 12, 2010 1239
EMEA Approves Update to Velcade(R) (bortezomib) Label to Include Survival Benefit in Previously Untreated Patients with Multiple Myeloma. Jun 15, 2010 964
EMA Approves Update to Velcade(R) (bortezomib) Label to Include Long Term (3 Year Follow up) Overall Survival Benefit in Previously Untreated Patients with Multiple Myeloma. Jun 15, 2010 1140
Takeda to Co-Promote VELCADE[R] (bortezomib) for Injection in Japan. May 10, 2010 1436
Journal of Clinical Oncology Publishes Data on Overall Survival Benefit of VELCADE[R] (Bortezomib) for Injection in Patients with Previously Untreated Multiple Myeloma. Apr 29, 2010 1560
CombinatoRx Discovers Novel Multi-Target Mechanism for the Treatment of Hematologic Malignancies. Apr 14, 2010 645
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma. Mar 29, 2010 843
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers. Mar 19, 2010 537
Disseminated plasmacytoma of the thyroid. Park, Brian J.; Kalish, Randy J.; Vercillo, Arthur P. Clinical report Mar 1, 2010 1318
More Good News for Myeloma Patients Could Change Patterns of Treatment. Dec 18, 2009 548
VELCADE[R] (Bortezomib) for Injection Based Therapy Delivers Sustained Overall Survival Advantage in Patients with Previously Untreated Multiple Myeloma. Clinical report Dec 8, 2009 1826
VELCADE[R] (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma. Clinical report Dec 7, 2009 1842
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma. Dec 7, 2009 1329
New 3-drug combo may effectively treat multiple myeloma. Dec 6, 2009 421
Multiple Myeloma Research Foundation's (MMRF) Fall Gala Raises More Than $1.8 Million to Advance Cancer Research. Oct 27, 2009 696
Cancer patients given a boost; A new treatment could give patients in the North East with certain types of cancer a greater chance of survival. Health Reporter HELEN RAE explains. Oct 26, 2009 607
New Way of Therapy for Multiple Myeloma Offered. Clinical report Oct 25, 2009 465
New treatment for North's blood cancer victims. Oct 17, 2009 213
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases. Sep 21, 2009 2604
Genzyme's Mozobil approved by EU for treating certain cancer patients requiring a stem cell transplant. Aug 1, 2009 241
The International Myeloma Foundation Says Medicare Decision to Cover PET Scans Can Improve Disease Staging and Treatment Planning. Apr 6, 2009 607
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma. Mar 2, 2009 805
VELCADE(R) (bortezomib) Findings Reinforce Efficacy and Survival Across Multiple Patient Populations. Dec 9, 2008 796
ImmunoGen, Inc. Announces Favorable IMGN901 Clinical Findings Reported at ASH Annual Meeting. Clinical report Dec 9, 2008 771
Gene variants can predict mortality in multiple myeloma. Sullivan, Michele G. Disease/Disorder overview Dec 1, 2008 848
Scleredema-associated IgA myeloma with myelofibrosis in a young adult: a case report/Genc bir yetiskinde miyelofibroz ile sklerema iliskili IgA miyelom: bir vaka raporu. Rao, Seema; Kar, Rakhee; Pati, Hara Prasad; Saxena, Renu Case study Dec 1, 2008 1237
A rare presentation of multiple myeloma: Tc-99m MIBI SPECT imaging of orbital involvement/Multiple myeloma'nin nadir bir gorunumu: Orbital tutulumun Tc-99m MIBI SPECT goruntulemesi. Sivrikoz, Ilknur Ak; Gulbas, Zafer Report Dec 1, 2008 555
'I've enough on my plate with fighting cancer, now I have to fight the NHS' Peter's appeal for treatment rejected by NHS Trust. Nov 22, 2008 572
Multiple Myeloma Research Foundation's (MMRF) Annual Gala Raises More Than $1.5 Million to Advance Cancer Research. Nov 4, 2008 502
As a treatment for multiple myeloma, autologous stem cell transplantation can be performed on an outpatient basis, resulting in shorter hospital stays and low treatment-related mortality, according to a report in the Mayo Clinic Proceedings for October. Brief article Oct 20, 2008 240
Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma. Oct 16, 2008 931
The Multiple Myeloma Research Consortium (MMRC) Announces Initiation of Phase 1B Study of Elotuzumab (HuLuc63) Monoclonal Antibody in Combination with REVLIMID and dexamethasone. Oct 13, 2008 665
The International Myeloma Foundation Applauds Expansion of VELCADE(R) for Previously Untreated Patients in Europe and Canada. Sep 29, 2008 486
A case of multiple myeloma with double malarial infection/Cifte malarya enfeksiyonlu multipl miyelom olgusu. Chandra, Harish; Chandra, Smita Case study Sep 1, 2008 363
Patients kept in dark over new drugs; The World Today. Aug 26, 2008 171
Cancer 'patients kept in the dark' Specialists not telling of new treatments. Aug 26, 2008 624
WALES: 'Cancer patients kept in the dark'. Aug 26, 2008 234
WORLD TODAY: Patients kept in the dark. Aug 26, 2008 96
Cancer patients 'kept in the dark'. Aug 26, 2008 102
Treatment woes. Aug 26, 2008 133
The Multiple Myeloma Research Consortium (MMRC) Announces Initiation of First Four-Drug Combination Study to Treat Newly Diagnosed Multiple Myeloma Patients. Aug 13, 2008 722
The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade. Report Jul 18, 2008 677
REVLIMID(R) Data for Newly Diagnosed Multiple Myeloma Reported at a Satellite Symposium During the 13th European Hematology Association Congress. Jun 16, 2008 1026
New Analysis of Phase III Studies Shows That REVLIMID(R) Plus Dexamethasone Yielded an Estimated Mean Survival of 5.6 Life Years for Patients with Multiple Myeloma. Jun 14, 2008 899
The International Myeloma Foundation Says Thalidomide Approval in Europe Could Provide Survival Benefits to Newly Diagnosed Myeloma Patients. Apr 21, 2008 607
Myeloma patients flock to Little Rock. Hengel, Mark Mar 24, 2008 1912
The International Myeloma Foundation Says Study Shows 90% Overall Response for Patients with New REVLIMID(R) Combination. Jan 4, 2008 586
Gloucester Pharmaceuticals Announces Positive Interim Results of Phase I/II Study in Patients with Multiple Myeloma at the 2007 American Society of Hematology (ASH) Annual Meeting. Dec 10, 2007 793
Extramedullary plasmacytoma of the larynx: A case report from Japan. Kusunoki, Takeshi; Ikeda, Katsuhisa; Murata, Kiyotaka; Nishida, Shozo; Tsubaki, Masanobu Dec 1, 2007 1270
Updated REVLIMID(R) (Lenalidomide) Plus Dexamethasone Data in Previously Treated Multiple Myeloma Reported in The New England Journal of Medicine. Clinical report Nov 21, 2007 1782
Moffitt Cancer Center Takes Part in Newly Published Study in This Week's New England Journal of Medicine. Report Nov 21, 2007 824
Thalidomide hope in cancer battle. Oct 5, 2007 305
Recurrence of isolated multiple myeloma in the skull base: a case report and review of the literature. Husein, Omar F.; Jacob, Abraham; Massick, Douglas D.; Welling, D. Bradley Clinical report Sep 1, 2007 2537
The diagnostic footprints--a case study. Hoy, Barbara A. Case study Aug 1, 2007 1260
Genzyme says phase 3 Mozobil trials meet primary endpoints for treating non-Hodgkin's lymphoma, multiple myeloma. Aug 1, 2007 474
The European Myeloma Platform Applauds the EMEA Approval of REVLIMID and Supports Efforts to Quickly Bring the Oral Therapy to Patients Across Europe. Jun 20, 2007 385
Revlimid(R) Clinical Study Reports Survival Advantage for Patients Newly Diagnosed With Multiple Myeloma at European Hematology Meeting. Clinical report Jun 11, 2007 1104
The approach to the management of multiple myeloma has changed over the past decade. Thomson, Jackie Clinical report Jun 1, 2007 1819
ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma. Apr 4, 2007 707
Millennium discovers biomarkers potentially predictive of response to VELCADE. Apr 1, 2007 717
Multiple myeloma responds to new regimens. Wilson, Bruce Mar 15, 2007 692
NCCN Updates Multiple Myeloma Guidelines. Jan 8, 2007 627
Giant cell arteritis mimicking multiple myeloma; diagnosed by PET scan. Patil, Soma S. Nov 1, 2006 1094
Lenalidomide is effective in relapsed multiple myeloma. Worcester, Sharon Feb 1, 2006 213
Pharmion Provides EU Registration Strategy Update for Thalidomide. Jan 10, 2006 1035
Diagnostic accuracy of Cystatin C as a marker of kidney disease in patients with multiple myeloma: calculated glomerular filtration rate formulas are equally useful. Lamb, Edmund J.; Stowe, Helen J.; Simpson, David E.; Coakley, Anthony J.; Newman, David J.; Leahy, M Oct 1, 2004 3421
Double stem cell transplant after HDC improves survival in multiple myeloma patients. Feb 16, 2004 382
Tandem transplant: 60% remission in Myeloma. (Reduced Relapse and Mortality). DeMott, Kathryn Mar 1, 2002 532
Novel agent stabilizes, aids refractory Myeloma. (Clinical Trials Slated for PS-341). DeMott, Kathryn Mar 1, 2002 325
CELLPRO BEGINS PHASE III TRIAL IN MULTIPLE MYELOMA; New Trial Designed to Demonstrate Tumor-Cell Depletion. Jan 16, 1995 784

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters